These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

315 related items for PubMed ID: 15669886

  • 1. Efficacy and tolerability of controlled-release paroxetine in the treatment of panic disorder.
    Sheehan DV, Burnham DB, Iyengar MK, Perera P, Paxil CR Panic Disorder Study Group.
    J Clin Psychiatry; 2005 Jan; 66(1):34-40. PubMed ID: 15669886
    [Abstract] [Full Text] [Related]

  • 2. Effectiveness of low doses of paroxetine controlled release in the treatment of major depressive disorder.
    Trivedi MH, Pigotti TA, Perera P, Dillingham KE, Carfagno ML, Pitts CD.
    J Clin Psychiatry; 2004 Oct; 65(10):1356-64. PubMed ID: 15491239
    [Abstract] [Full Text] [Related]

  • 3. Double-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorder.
    Ballenger JC, Wheadon DE, Steiner M, Bushnell W, Gergel IP.
    Am J Psychiatry; 1998 Jan; 155(1):36-42. PubMed ID: 9433336
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and tolerability of controlled-release and immediate-release paroxetine in the treatment of depression.
    Golden RN, Nemeroff CB, McSorley P, Pitts CD, Dubé EM.
    J Clin Psychiatry; 2002 Jul; 63(7):577-84. PubMed ID: 12143913
    [Abstract] [Full Text] [Related]

  • 5. A randomized controlled trial of venlafaxine ER and paroxetine in the treatment of outpatients with panic disorder.
    Pollack M, Mangano R, Entsuah R, Tzanis E, Simon NM, Zhang Y.
    Psychopharmacology (Berl); 2007 Oct; 194(2):233-42. PubMed ID: 17589833
    [Abstract] [Full Text] [Related]

  • 6. A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder.
    Pollack MH, Lepola U, Koponen H, Simon NM, Worthington JJ, Emilien G, Tzanis E, Salinas E, Whitaker T, Gao B.
    Depress Anxiety; 2007 Oct; 24(1):1-14. PubMed ID: 16894619
    [Abstract] [Full Text] [Related]

  • 7. Long-term evaluation of paroxetine, clomipramine and placebo in panic disorder. Collaborative Paroxetine Panic Study Investigators.
    Lecrubier Y, Judge R.
    Acta Psychiatr Scand; 1997 Feb; 95(2):153-60. PubMed ID: 9065681
    [Abstract] [Full Text] [Related]

  • 8. A comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder. Collaborative Paroxetine Panic Study Investigators.
    Lecrubier Y, Bakker A, Dunbar G, Judge R.
    Acta Psychiatr Scand; 1997 Feb; 95(2):145-52. PubMed ID: 9065680
    [Abstract] [Full Text] [Related]

  • 9. [Efficacy and tolerability of escitalopram in anxiety disorders: a review].
    Pelissolo A.
    Encephale; 2008 Sep; 34(4):400-8. PubMed ID: 18922243
    [Abstract] [Full Text] [Related]

  • 10. Paroxetine, clomipramine, and cognitive therapy in the treatment of panic disorder.
    Bakker A, van Dyck R, Spinhoven P, van Balkom AJ.
    J Clin Psychiatry; 1999 Dec; 60(12):831-8. PubMed ID: 10665629
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of controlled-release paroxetine in the treatment of late-life depression.
    Rapaport MH, Schneider LS, Dunner DL, Davies JT, Pitts CD.
    J Clin Psychiatry; 2003 Sep; 64(9):1065-74. PubMed ID: 14628982
    [Abstract] [Full Text] [Related]

  • 12. Venlafaxine extended release vs placebo and paroxetine in social anxiety disorder.
    Liebowitz MR, Gelenberg AJ, Munjack D.
    Arch Gen Psychiatry; 2005 Feb; 62(2):190-8. PubMed ID: 15699296
    [Abstract] [Full Text] [Related]

  • 13. Paroxetine in the treatment of panic disorder. A randomised, double-blind, placebo-controlled study.
    Oehrberg S, Christiansen PE, Behnke K, Borup AL, Severin B, Soegaard J, Calberg H, Judge R, Ohrstrom JK, Manniche PM.
    Br J Psychiatry; 1995 Sep; 167(3):374-9. PubMed ID: 7496647
    [Abstract] [Full Text] [Related]

  • 14. Controlled-release paroxetine in the treatment of patients with social anxiety disorder.
    Lepola U, Bergtholdt B, St Lambert J, Davy KL, Ruggiero L.
    J Clin Psychiatry; 2004 Feb; 65(2):222-9. PubMed ID: 15003077
    [Abstract] [Full Text] [Related]

  • 15. Paroxetine controlled release for premenstrual dysphoric disorder: a double-blind, placebo-controlled trial.
    Cohen LS, Soares CN, Yonkers KA, Bellew KM, Bridges IM, Steiner M.
    Psychosom Med; 2004 Feb; 66(5):707-13. PubMed ID: 15385695
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and tolerability of controlled-release paroxetine in the treatment of severe depression: post hoc analysis of pooled data from a subset of subjects in four double-blind clinical trials.
    Dunner DL, Lipschitz A, Pitts CD, Davies JT.
    Clin Ther; 2005 Dec; 27(12):1901-11. PubMed ID: 16507376
    [Abstract] [Full Text] [Related]

  • 17. A double-blind, placebo-controlled, parallel-group, flexible-dose study of venlafaxine extended release capsules in adult outpatients with panic disorder.
    Liebowitz MR, Asnis G, Mangano R, Tzanis E.
    J Clin Psychiatry; 2009 Apr; 70(4):550-61. PubMed ID: 19358784
    [Abstract] [Full Text] [Related]

  • 18. Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.
    Foster RH, Goa KL.
    CNS Drugs; 1997 Aug; 8(2):163-88. PubMed ID: 23338224
    [Abstract] [Full Text] [Related]

  • 19. Sertraline versus paroxetine in the treatment of panic disorder: an acute, double-blind noninferiority comparison.
    Bandelow B, Behnke K, Lenoir S, Hendriks GJ, Alkin T, Goebel C, Clary CM.
    J Clin Psychiatry; 2004 Mar; 65(3):405-13. PubMed ID: 15096081
    [Abstract] [Full Text] [Related]

  • 20. A randomized, double-blind, placebo-controlled study of the effects of adjunctive paroxetine in panic disorder patients unsuccessfully treated with cognitive-behavioral therapy alone.
    Kampman M, Keijsers GP, Hoogduin CA, Hendriks GJ.
    J Clin Psychiatry; 2002 Sep; 63(9):772-7. PubMed ID: 12363116
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.